Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.
about
Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzymeThe evolutionary portrait of metazoan NAD salvageA phosphoenzyme mimic, overlapping catalytic sites and reaction coordinate motion for human NAMPTStructure and reaction mechanism of human nicotinamide phosphoribosyltransferaseCrystal structure and biochemical analyses reveal Beclin 1 as a novel membrane binding proteinStructure of Salmonella typhimurium OMP Synthase in a Complete Substrate ComplexStructural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferaseExtracellular nicotinamide phosphoribosyltransferase, a new cancer metabokineBiochemical characterization of quinolinic acid phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv and inhibition of its activity by pyrazinamideStructural basis for resistance to diverse classes of NAMPT inhibitorsInsulin resistance in chronic kidney disease: a systematic review.NAMPT and NAPRT1: novel polymorphisms and distribution of variants between normal tissues and tumor samples.Structure-activity relationship analysis of cytotoxic cyanoguanidines: selection of CHS 828 as candidate drugIdentification of novel pathogenic copy number aberrations in multiple myeloma: the Malaysian contextAdipose tissue NAD+ biology in obesity and insulin resistance: From mechanism to therapy"Clocks" in the NAD World: NAD as a metabolic oscillator for the regulation of metabolism and agingNicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery.P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvageThe NAMPT promoter is regulated by mechanical stress, signal transducer and activator of transcription 5, and acute respiratory distress syndrome-associated genetic variants.Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase.Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activityHepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene.The NAD World: a new systemic regulatory network for metabolism and aging--Sirt1, systemic NAD biosynthesis, and their importanceIs PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome?Nicotinamide phosphoribosyltransferase is essential for interleukin-1beta-mediated dedifferentiation of articular chondrocytes via SIRT1 and extracellular signal-regulated kinase (ERK) complex signalingNutritional energy stimulates NAD+ production to promote tankyrase-mediated PARsylation in insulinoma cellsFibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1α in human dopaminergic neurons via Sirtuin-1.Nicotinamide Phosphoribosyltransferase in Human Diseases.SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice.Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis.Unique Toll-Like Receptor 4 Activation by NAMPT/PBEF Induces NFκB Signaling and Inflammatory Lung InjuryGlucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of NamptAdipokines and melanocortins in the hepatic manifestation of metabolic syndrome: nonalcoholic fatty liver disease.Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism.Deacetylation by SIRT1 Reprograms Inflammation and CancerPre-B cell colony enhancing factor (PBEF), a cytokine with multiple physiological functions.The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing.Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases.Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes.Nampt: linking NAD biology, metabolism and cancer.
P2860
Q24299618-01AE3FE8-6464-4F85-85AD-4B9A1BF81648Q27318392-A2195B4C-39CF-49C9-8804-ACA1B5FE9C18Q27656939-F96DBF22-7C9C-4E14-ADC2-F34731CCEE6CQ27657748-1CF6556D-3B39-4EA2-9317-9974AAB2A4A1Q27677125-2B17E1E9-6008-4362-8204-331C3DEE09BEQ27678717-819C1001-04C5-4E91-9DC3-BC6096A421AAQ27690154-47E7DE66-59F5-47C0-A073-D701BC32322FQ28069876-0DE7E44F-58DF-4811-99AA-0AB7CA3FE417Q28539893-CABD7E30-EA74-4A9C-804F-DC9F43F3B2E3Q28543568-EEAE1F81-F800-4949-B2CF-3DF52B040380Q30244271-7B5C03AA-8D2E-4A21-8485-8999368A9CB9Q30366556-DE337F49-FA98-41A8-88E9-4DB409363BB3Q33475966-42F7241B-D2A3-4471-85F6-7A33A3522BE5Q33614522-91E49B4A-8416-48DF-B8DD-1C2797A35084Q33791807-4442AA8B-E413-4B4C-982D-82BF90232C8DQ33915457-2B0EA88E-B437-4B90-B2D9-0B48C33FBCDDQ34003813-4BA2854E-2C97-4C1F-8E43-50F07EF5D201Q34174808-AECEC117-A99E-4B0D-9C6C-B0EE53C9929DQ34471247-F7C41329-B215-40F8-BECD-D8A15A53526FQ34482044-A217E872-46EC-4CBE-B397-CD71AE698378Q34634272-0D098705-AFDE-4E86-84FB-947DA7C779DCQ34800558-CB6102A6-F5B6-4090-9B9E-4F768CA8AB70Q34917651-5FCC7AAF-E78C-45A0-9296-4C0456BF74CAQ34993305-BA2FBE2E-BDBC-4206-A333-F32F88E35D23Q35150292-7A3199DF-C557-4128-9516-158D88190356Q35392914-529670BC-8765-4690-A403-7B4AD29E21CFQ35537540-9A44ED7C-C7E3-4537-8194-7400C4E88513Q35581515-41279FF2-2DBB-4B64-96EC-DB3BF072948AQ35588961-2284B3C6-A702-4ECB-9B6D-C298A48D20D2Q35876759-05D8AA1F-ABA3-48B8-BA75-45287EF3CC40Q35953849-3BD0FE90-3C76-40A9-ADB9-4AFB34AA8048Q36728127-87291C44-07BE-4CBD-AEE3-397ADA48AE03Q36748514-847E6F5F-9D42-4472-98BE-E412EF1248CFQ37000257-F0FD2C9E-32DB-4BE1-87B8-0E786730FCE1Q37150502-79AA5B31-0C77-40D4-9CC9-0F063F42B9D7Q37216851-F796F764-3228-460B-9E30-BD75581BAA29Q37285835-36D181BE-D410-491F-B674-EF91DE399F69Q37324960-49B10C4E-C44C-4271-9C72-6DD24675716AQ37324972-8591F946-6524-4440-8C6E-2C75975CDB47Q37334248-6152C178-A8FA-4CA3-AA37-736D0E75F434
P2860
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.
@ast
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.
@en
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.
@nl
type
label
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.
@ast
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.
@en
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.
@nl
prefLabel
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.
@ast
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.
@en
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.
@nl
P2093
P2860
P356
P1476
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme
@en
P2093
Javier R Revollo
Poonam Bheda
Shin-ichiro Imai
Xiangbin Zhang
P2860
P2888
P304
P356
10.1038/NSMB1114
P577
2006-06-18T00:00:00Z